Daniel Woronow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers have found 36 cases of acute cholecystitis associated with the use of GLP-1 receptor agonists in the U.S., according to findings from the FDA Adverse Event Reporting System published in JAMA Internal Medicine. “The required labeling for some GLP-1 receptor agonists indicated for glycemic control in patients with type 2 diabetes include warnings and precautions regarding acute

Patients who take glucagon-like peptide-1 receptor agonists for weight loss or management of diabetes may be at risk of acute gallbladder disease. USA: In a recent study published as a research letter...

FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists